Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 24, 2015 - Issue 11
Submit an article Journal homepage
364
Views
9
CrossRef citations to date
0
Altmetric
Review

Potential breakthroughs with investigational drugs for hairy cell leukemia

Tadeusz RobakMedical University of Lodz, Copernicus Memorial Hospital, Department of Hematology, 93-510 Lodz, ul. Ciołkowskiego 2, Lodz, Poland+48 426 895 191; +48 426 895 192; [email protected]
, MD PhD,
Anna WolskaMedical University of Lodz, Copernicus Memorial Hospital, Department of Hematology, 93-510 Lodz, ul. Ciołkowskiego 2, Lodz, Poland+48 426 895 191; +48 426 895 192; [email protected]
, MD PhD &
Pawel RobakMedical University of Lodz, Department of Experimental Hematology, 93-510 Lodz, ul. Ciołkowskiego 2, Lodz, Poland
, MD PhD
Pages 1419-1431 | Published online: 21 Aug 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Agnieszka Janus & Tadeusz Robak. (2019) Moxetumomab pasudotox for the treatment of hairy cell leukemia. Expert Opinion on Biological Therapy 19:6, pages 501-508.
Read now
Anna Wolska-Washer, Pawel Robak, Piotr Smolewski & Tadeusz Robak. (2017) Emerging antibody-drug conjugates for treating lymphoid malignancies. Expert Opinion on Emerging Drugs 22:3, pages 259-273.
Read now

Articles from other publishers (7)

Anna Wolska-Washer & Piotr Smolewski. (2022) Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies. Cancers 14:15, pages 3778.
Crossref
L.S. Al-Radi, Svetlana Yurevna Smirnova, T.N. Moiseeva, I.S. Piskunova, L.V. Plastinina, D.V. Novikova, E.G. Gemdzhian & G.M. Galstyan. (2022) Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia. Clinical oncohematology 15:4, pages 349-355.
Crossref
Ewa Robak, Dorota Jesionek-Kupnicka & Tadeusz Robak. (2020) Skin changes in hairy cell leukemia. Annals of Hematology 100:3, pages 615-625.
Crossref
Tadeusz Robak & Sascha Dietrich. 2021. Indolent Lymphomas. Indolent Lymphomas 179 194 .
Pawel Robak, Dorota Jesionek‐Kupnicka, Piotr Kupnicki, Aaron Polliack & Tadeusz Robak. (2020) Bone lesions in hairy cell leukemia: Diagnosis and treatment. European Journal of Haematology 105:6, pages 682-691.
Crossref
Karen M Fancher & Zachary C Lally-Montgomery. (2019) Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemia. Journal of Oncology Pharmacy Practice 25:6, pages 1467-1472.
Crossref
Daniel P. ShenoiLeslie A. Andritsos, James S. Blachly, Kerry A. Rogers, Mollie E. Moran, Mirela Anghelina, Jeffrey A. Jones & Michael R. Grever. (2019) Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib. Blood Advances 3:2, pages 116-118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.